The driver of benefit appears to be the amount of weight lost at 10 years, but the surgery also likely eases OSA symptoms.
Guidelines have downgraded the practice, but new registry data show no increase in bleeding, making a case for pretreatment.
Reteplase appears to be another safe and effective thrombolytic option for the treatment of acute ischemic stroke, according ...
Bioprosthetic valve thrombosis found on imaging—with no symptoms reported by the patient—presents a conundrum for clinicians.
The good news is likely thanks to quality healthcare in Denmark, researchers say, but even with that there’s room to improve.
Even since April when the RELIEVE-HF trial came out showing no benefit to an investigational interatrial shunt for heart ...
Those who knew him recall a passionate physician and generous collaborator who brought “intellect and zaniness” to his work.
With the first positive results from a cardiogenic-shock RCT in hand, researchers are brainstorming what should come next.
The findings were published in the Journal of the American College of Cardiology ahead of Juneteenth, the day marking the end ...
The combination of involving pharmacists and using an algorithm to manage GDMT cut LDL levels by 50% in OPTIMIZE PAD-1.
People whose LDL cholesterol is in the normal range—even those without metabolic risk factors—may yet have levels of ...
Some are calling for a randomized trial, but whether anyone would be willing to randomize is another question entirely.